Skip to content
Health and Human Services (HHS) is set to assess three drug payment models for Medicare and Medicaid in response to President Biden’s proposal to […]
HHS releases new drug payment models—here’s what you need to know Read More »
On Thursday, the Centers for Medicare & Medicaid Services (CMS) released its proposed timeline for penalizing drug makers whose prices rise faster than inflation.
CMS releases timeline for inflation rebate on drug price increases Read More »
The Biotechnology Innovation Organization (BIO) recently told the U.S. Patent and Trademark Office (USPTO) that proposed changes to the pharmaceutical patent process are flawed—and
BIO says that proposed changes to pharma patents would harm innovation Read More »
Partisan divisions were on display at a joint hearing of the House Energy & Commerce Committee’s Health and Oversight & Investigations subcommittees, as Republicans
Administration officials return to Congress to discuss COVID-19 response Read More »
In his State of the Union speech last night, President Joe Biden hailed the end of the COVID-19 emergency while ignoring the contribution of
State of the Union: Biden’s remarks on drug price controls and biomedical innovation Read More »
The Inflation Reduction Act’s drug price controls have been a hot topic during the BIO CEO and Investor Conference—and one that has hampered an
We’re already seeing the impact of drug price controls, say biotech CEOs Read More »
With the 118th Congress picking up steam, the Biotechnology Innovation Organization’s (BIO) Federal Government Relations team shared what to expect in health care and
What BIO’s watching on health care and agriculture policy in 2023 Read More »
In a move that will help the 340B pharmaceutical discount program get back on track, the U.S. Third Circuit Court of Appeals decided Monday
Federal court rules against HHS on 340B contract pharmacies Read More »
Yesterday, the Biotechnology Innovation Organization’s (BIO) Clinical Trial Diversity Roundtable brought together leaders from government, industry, and patient groups to begin implementing the clinical
BIO roundtable works toward greater clinical trial diversity Read More »
A significant date for biotechnology and the historic fight to create vaccines, the Biden administration will end the COVID-19 public health emergency on May
U.S. COVID public health emergency will end in May Read More »
